Transaction · 0001479290-25-000005

Schilke Tobin

Schilke Tobin, CFO, reported a transaction classified as grant at Revance Therapeutics, Inc. involving 1000.000000 shares for an estimated $2184.50. Reported holdings after the transaction were 194666.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
RVNCRevance Therapeutics, Inc.
Filing timeJan 03
Trade dateDec 31, 2024
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

RVNC price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RVNC since 2025-01-03Filed 608 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001479290-25-000005
Common Stock
Transaction date
Dec 31, 2024
Filed Jan 03, 2025, 09:34 PM · 3d delay
Shares
1.00k sh
$218 per share
Estimated value
$218k
Computed from shares × price
Holdings after
194k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These shares were acquired by Mr. Schilke under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Original filing · 0001479290-25-000005
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RVNC